ABSTRACT
Dystroglycanopathies are a heterogeneous group of disorders caused by defects in the glycosylation pathway of alpha-dystroglycan. The clinical spectrum ranges from severe congenital muscular dystrophy with structural brain and eye involvement to a relatively mild adult onset limb-girdle muscular dystrophy without brain abnormalities and normal intelligence. Mutations have been identified in one of six putative or demonstrated glycosyltransferases. Many different FKRP mutations have been identified, which cover the complete clinical spectrum of dystroglycanopathies. In contrast to the other known genes involved in these disorders, genotype-phenotype correlations are not obvious for FKRP mutations. To date, no homozygous or compound heterozygous null mutations have been identified in FKRP, suggesting that null mutations in FKRP could result in embryonic lethality. We report a family with two siblings carrying a homozygous mutation in the start codon of FKRP that is likely to result in a loss of functional FKRP protein. The clinical phenotype of the patients was consistent with Walker-Warburg syndrome, the most severe disorder in the disease spectrum of dystroglycanopathies.
Subject(s)
Codon, Initiator/genetics , Mutation , Proteins/genetics , Walker-Warburg Syndrome/genetics , Base Sequence , DNA Mutational Analysis , Fatal Outcome , Female , Homozygote , Humans , Infant, Newborn , Male , Pedigree , Pentosyltransferases , Severity of Illness Index , Siblings , Walker-Warburg Syndrome/pathologySubject(s)
Collodion/metabolism , Ichthyosis, Lamellar/genetics , Ichthyosis, Lamellar/pathology , Mutation/genetics , Transglutaminases/genetics , Diseases in Twins/genetics , Diseases in Twins/pathology , Genetic Association Studies , Genetic Predisposition to Disease , Genotype , Humans , Infant, Newborn , Male , Phenotype , Remission, Spontaneous , TemperatureABSTRACT
PURPOSE: To identify the biochemical and molecular genetic defect in a 16-year-old patient presenting with apical hypertrophic cardiomyopathy and neuropathy suspected for a mitochondrial disorder. METHODS: Measurement of the mitochondrial energy-generating system (MEGS) capacity in muscle and enzyme analysis in muscle and fibroblasts were performed. Relevant parts of the mitochondrial DNA were analysed by sequencing. Transmitochondrial cybrids were obtained by fusion of 143B206 TK(-) rho zero cells with patient-derived enucleated fibroblasts. Immunoblotting techniques were applied to study the complex V assembly. RESULTS: A homoplasmic nonsense mutation m.8529G-->A (p.Trp55X) was found in the mitochondrial ATP8 gene in the patient's fibroblasts and muscle tissue. Reduced complex V activity was measured in the patient's fibroblasts and muscle tissue, and was confirmed in cybrid clones containing patient-derived mitochondrial DNA. Immunoblotting after blue native polyacrylamide gel electrophoresis showed a lack of holocomplex V and increased amounts of mitochondrial ATP synthase subcomplexes. An in-gel activity assay of ATP hydrolysis showed activity of free F(1)-ATPase in the patient's muscle tissue and in the cybrid clones. CONCLUSION: We describe the first pathogenic mutation in the mitochondrial ATP8 gene, resulting in an improper assembly and reduced activity of the complex V holoenzyme.
Subject(s)
Cardiomyopathy, Hypertrophic/enzymology , Cardiomyopathy, Hypertrophic/genetics , Codon, Nonsense , Genes, Mitochondrial , Mitochondrial Proton-Translocating ATPases/deficiency , Mitochondrial Proton-Translocating ATPases/genetics , Nervous System Diseases/enzymology , Nervous System Diseases/genetics , Adolescent , Amino Acid Sequence , Base Sequence , DNA Primers/genetics , Humans , Hybrid Cells , Male , Mitochondrial Diseases/enzymology , Mitochondrial Diseases/genetics , Mitochondrial Proton-Translocating ATPases/chemistry , Molecular Sequence Data , Sequence Homology, Amino AcidABSTRACT
BACKGROUND: The heterogeneity of mitochondrial cytopathies is characteristic for this group of disorders, which preferentially affect the muscle and nerve system. The A3243G transition in the tRNA(Leu(UUR)) gene has been associated with slowly progressive forms of focal segmental glomerulosclerosis (FSGS). Here we present a patient who developed a severe nephrotic syndrome during her first pregnancy, which persisted after delivery, and proved resistant to immunosuppressive therapy. A sister of our patient had developed diabetes mellitus. We analysed the DNA for the presence of the mitochondrial DNA (mtDNA) A3243G transition. METHODS: DNA was isolated from peripheral blood leukocytes and urine sediments. Polymerase chain reaction was performed to amplify the mtDNA. Restriction enzyme analysis was used to detect the presence of the A3243G transition. Quantitative analysis of the A3243G mutation was done using the pyrosequencing technique. RESULTS: Quantitative analysis revealed a proportion of mutated mtDNA of 30% in the leukocytes and 68% in the urine sediments of the proband. On further analysis, we also found the transition in the mother, the diabetic sister and the daughter of the proband. CONCLUSION: MtDNA abnormalities can cause a steroid-resistant nephrotic syndrome, histologically characterized by FSGS. Physicians should be especially mindful of mitochondrial abnormalities when hearing loss, diabetes mellitus or neuromuscular disorders are present in the patient or family members.
Subject(s)
DNA, Mitochondrial/genetics , Nephrotic Syndrome/genetics , RNA, Transfer, Leu/genetics , Adult , Base Sequence , DNA/blood , DNA/isolation & purification , DNA Primers , Female , Humans , Kidney/pathology , Male , Mutation, Missense , Pedigree , Polymerase Chain ReactionABSTRACT
CONTEXT: Dyslexia is a common disorder with a strong genetic component, but despite significant research effort, the aetiology is still largely unknown. OBJECTIVE: To identify loci contributing to dyslexia risk. METHODS: This was a genomewide linkage analysis in a single large family. Dutch families with at least two first degree relatives suffering from dyslexia participated in the study. Participants were recruited through an advertisement campaign in papers and magazines. The main outcome measure was linkage between genetic markers and dyslexia phenotype. RESULTS: Using parametric linkage analysis, we found strong evidence for a locus influencing dyslexia on Xq27.3 (multipoint lod = 3.68). Recombinations in two family members flanked an 8 cM region, comprising 11 currently confirmed genes. All four males carrying the risk haplotype had very low scores on the reading tests. The presentation in females was more variable, but 8/9 females carrying the risk haplotype were diagnosed dyslexic by our composite score, so we considered the putative risk allele to be dominant with reduced penetrance. Linkage was not found in an additional collection of affected sibling pairs. CONCLUSIONS: A locus influencing dyslexia risk is probably located between markers DXS1227 and DXS8091 on the X chromosome, closely situated to a locus indicated by a published genome scan of English sibling pairs. Although the locus may not be a common cause for dyslexia, the relatively small and gene poor region offers hope to identify the responsible gene.
Subject(s)
Chromosomes, Human, X/genetics , Dyslexia/genetics , Genetic Predisposition to Disease/genetics , Adolescent , Adult , Aged , Alleles , DNA Mutational Analysis , Female , Genes, Dominant/genetics , Genetic Diseases, X-Linked/genetics , Genome, Human , Humans , Lod Score , Male , Middle Aged , Netherlands , Pedigree , Quantitative Trait Loci/genetics , Reading , Sex Characteristics , Siblings , Surveys and QuestionnairesABSTRACT
INTRODUCTION: Array comparative genomic hybridisation (array CGH) is a powerful method that detects alteration of gene copy number with greater resolution and efficiency than traditional methods. However, its ability to detect disease causing duplications in constitutional genomic DNA has not been shown. We developed an array CGH assay for X linked hypopituitarism, which is associated with duplication of Xq26-q27. METHODS: We generated custom BAC/PAC arrays that spanned the 7.3 Mb critical region at Xq26.1-q27.3, and used them to search for duplications in three previously uncharacterised families with X linked hypopituitarism. RESULTS: Validation experiments clearly identified Xq26-q27 duplications that we had previously mapped by fluorescence in situ hybridisation. Array CGH analysis of novel XH families identified three different Xq26-q27 duplications, which together refine the critical region to a 3.9 Mb interval at Xq27.2-q27.3. Expression analysis of six orthologous mouse genes from this region revealed that the transcription factor Sox3 is expressed at 11.5 and 12.5 days after conception in the infundibulum of the developing pituitary and the presumptive hypothalamus. DISCUSSION: Array CGH is a robust and sensitive method for identifying X chromosome duplications. The existence of different, overlapping Xq duplications in five kindreds indicates that X linked hypopituitarism is caused by increased gene dosage. Interestingly, all X linked hypopituitarism duplications contain SOX3. As mutation of this gene in human beings and mice results in hypopituitarism, we hypothesise that increased dosage of Sox3 causes perturbation of pituitary and hypothalamic development and may be the causative mechanism for X linked hypopituitarism.
Subject(s)
Chromosomes, Human, X/genetics , DNA-Binding Proteins/genetics , Gene Duplication , Genes, Duplicate/genetics , Genetic Diseases, X-Linked/genetics , High Mobility Group Proteins/genetics , Hypopituitarism/genetics , Transcription Factors/genetics , Adolescent , Adult , Animals , Child , Child, Preschool , Female , Gene Expression Regulation, Developmental , Genetic Linkage/genetics , Genome, Human , Humans , Hypothalamus/embryology , Hypothalamus/metabolism , In Situ Hybridization, Fluorescence , Infant , Infant, Newborn , Male , Mice , Nucleic Acid Hybridization , Pedigree , Pituitary Gland/embryology , Pituitary Gland/metabolism , Reproducibility of Results , SOXB1 Transcription FactorsABSTRACT
A 13-year-old girl with non-familial exercise intolerance, muscle pain and lactic acidaemia underwent a muscle biopsy for suspected mitochondrial disease. Muscle morphology showed 25% ragged-red fibres and 80% COX-negative staining. Enzymatic activities of mitochondrially co-encoded respiratory chain enzymes (complexes I, III, and IV) were decreased in muscle but normal in cultured skin fibroblasts. mtDNA analysis revealed the presence of the 7497G>A mutation in the tRNASer(UCN) gene, homoplasmic in skeletal muscle and 90% in leukocytes. Analysis of the mother's mtDNA showed 10% heteroplasmy in blood. It may be concluded that the 7497G>A mutation is associated with a muscle-only disease presentation for which high levels of mutated mtDNA are required. Exercise intolerance and muscle pain in otherwise normal children warrants further mitochondrial evaluation.
Subject(s)
Acidosis, Lactic/genetics , Exercise Tolerance/genetics , Muscular Diseases/genetics , Pain/genetics , RNA, Transfer, Ser/genetics , Acidosis, Lactic/complications , Adolescent , Brain/pathology , DNA, Mitochondrial/genetics , Electrocardiography , Electroencephalography , Electromyography , Evoked Potentials, Auditory/physiology , Evoked Potentials, Somatosensory/physiology , Female , Fibroblasts/enzymology , Humans , Magnetic Resonance Imaging , Muscle, Skeletal/enzymology , Muscle, Skeletal/pathology , Muscular Diseases/pathology , Oxidation-Reduction , Pain/complications , Reverse Transcriptase Polymerase Chain ReactionSubject(s)
DNA-Binding Proteins/genetics , Membrane Proteins/genetics , Neural Tube Defects/genetics , Protein-Tyrosine Kinases/genetics , Transcription Factors/genetics , CSK Tyrosine-Protein Kinase , Calmodulin-Binding Proteins , DNA/chemistry , DNA/genetics , DNA Mutational Analysis , DNA, Complementary/chemistry , DNA, Complementary/genetics , Gene Frequency , Genotype , Humans , Microfilament Proteins , Models, Genetic , Mutation , Polymorphism, Genetic , Polymorphism, Single-Stranded Conformational , Sequence Deletion , Transcription Factor AP-2 , src-Family KinasesABSTRACT
We describe two children carrying an inherited T899C mutation in the mitochondrial ATPase 6 gene with mild encephalopathy and normal postnatal growth followed by tall stature and obesity. No familial tall stature, endocrine anomaly or advanced skeletal age were present. Failure to thrive is a characteristic finding in most patients with a mitochondrial disease. Our observations suggest that children with encephalomyopathy, even in the presence of a significant clinical overgrowth, should be screened for a possible defect in oxidative phosphorylation.
Subject(s)
Body Height/physiology , Mitochondrial Encephalomyopathies/pathology , Obesity/physiopathology , Adolescent , Aging/physiology , Body Height/genetics , Child , DNA, Mitochondrial/genetics , Female , Growth/genetics , Growth/physiology , Humans , Mitochondrial Encephalomyopathies/genetics , Mitochondrial Encephalomyopathies/psychology , Obesity/etiology , Obesity/genetics , Point Mutation/geneticsABSTRACT
We investigated a family with a duplication, dup(X)q26-q27, that was present in two brothers, their mother, and their maternal grandmother. The brothers carrying the duplication displayed spina bifida and panhypopituitarism, whereas a third healthy brother inherited the normal X chromosome. Preferential inactivation of the X chromosome containing the duplication was evident in healthy carrier females. We determined the boundaries of the Xq26-q27 duplication. Via interphase FISH analysis we narrowed down each of the two breakpoint regions to approximately 300-kb intervals. The proximal breakpoint is located in Xq26.1 between DXS1114 and HPRT and is contained in YAC yWXD599, while the distal breakpoint is located in Xq27.3 between DXS369 and DXS1200 and contained in YAC yWXD758. The duplication comprises about 13 Mb. Evidence from the literature points to a predisposing gene for spina bifida in Xq27. We hypothesize that the spina bifida in the two brothers may be due to interruption of a critical gene in the Xq27 breakpoint region. Several candidate genes were mapped to the Xq27 critical region but none was shown to be disrupted by the duplication event. Recently, M. Lagerström-Fermér et al. (1997, Am. J. Hum. Genet. 60, 910-916) reported on a family with X-linked recessive panhypopituitarism associated with a duplication in Xq26; however, no details were reported on the extent of the duplication. Our study corroborates their hypothesis that X-linked recessive panhypopituitarism is likely to be caused by a gene encoding a dosage-sensitive protein involved in pituitary development. We place the putative gene between DXS1114 and DXS1200, corresponding to the interval defined by the duplication in the present family.
Subject(s)
Chromosome Aberrations , Hypopituitarism/genetics , Spinal Dysraphism/genetics , X Chromosome , Chromosome Mapping , Chromosomes, Artificial, Yeast , Dosage Compensation, Genetic , Expressed Sequence Tags , Female , Gene Order , Haplotypes/genetics , Heterozygote , Humans , Male , PedigreeABSTRACT
Bent tail is a mouse model for human neural tube defects. Bent tail mice are characterized by a shortened, kinked tail. We have observed numerous aberrations in Bent tail embryos including exencephaly, rotation defects and occasionally omphalocele, orofacial schisis and situs abnormalities. Exencephaly was seen in >10% of all embryos and resulted from a closure defect of the hindbrain. Bent tail maps to the proximal part of the X chromosome. By haplotype analysis we have appointed the Bent tail locus to a 1.1 cM interval between markers DXMit159 and DXMit143. Subsequent analysis has revealed the presence of a deletion in all affected animals. The deletion is approximately 1 Mb in size and encompasses the gene for ZIC:3, a zinc finger transcription factor expressed in murine neuroectoderm and dorsal axial mesoderm during neurulation. ZIC:3 is a homolog of the Drosophila segmentation gene odd-paired. Although the Bent tail phenotype probably is the result of the deletion of several genes, combining data on ZIC:3 expression and function of ZIC: genes in the mouse shows that deletion of Zic3 alone is compatible with a major role of this gene in the congenital malformations of the Bent tail mouse. In man, mutations in ZIC3 are associated with situs abnormalities. These patients occasionally also show spina bifida, indicating that genetic variation in human ZIC3 may contribute to other congenital malformations, including neural tube defects.
Subject(s)
Homeodomain Proteins/genetics , Neural Tube Defects/genetics , Tail/abnormalities , Transcription Factors/genetics , X Chromosome/genetics , Animals , Chromosome Mapping , DNA/genetics , Disease Models, Animal , Embryo, Mammalian/abnormalities , Embryo, Mammalian/metabolism , Female , Gene Deletion , Genetic Linkage , Guanine Nucleotide Exchange Factors , Humans , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Inbred CBA , Mice, Inbred DBA , Mice, Inbred Strains , Phenotype , Proto-Oncogene Proteins/genetics , Tail/embryologyABSTRACT
The nail patella syndrome (NPS1) is an autosomal dominant disorder characterised by dysplasia of the finger nails and skeletal abnormalities. NPS1 has been mapped to 9q34, to a 1 cM interval between D9S315 and the adenylate kinase gene (AK1). We have mapped the breakpoints within the candidate NPS1 region in two unrelated patients with balanced translocations. One patient [46,XY,t(1;9)(q32.1;q34)] was detected during a systematic survey of old cytogenetic files in Denmark and southern Sweden. The other patient [46,XY,t(9;17)(q34.1;q25)] was reported previously. D9S315 and AK1 were used to isolate YACs, from which endclones were used to isolate PACs. Two overlapping PAC clones span the 9q34 breakpoints in both patients, suggesting that NPS1 is caused by haploinsufficiency due to truncation or otherwise inactivation of a gene at or in the vicinity of the breakpoints.
Subject(s)
Chromosome Fragility , Chromosomes, Human, Pair 9 , Nail-Patella Syndrome/genetics , Chromosomes, Artificial, Yeast , Cloning, Molecular , Humans , In Situ Hybridization, Fluorescence , Infant , Translocation, GeneticABSTRACT
Mouse models show that congenital neural tube defects (NTDs) can occur as a result of mutations in the platelet-derived growth factor receptor-alpha gene (PDGFRalpha). Mice heterozygous for the PDGFRalpha-mutation Patch, and at the same time homozygous for the undulated mutation in the Pax1 gene, exhibit a high incidence of lumbar spina bifida occulta, suggesting a functional relation between PDGFRalpha and Pax1. Using the human PDGFRalpha promoter linked to a luciferase reporter, we show in the present paper that Pax1 acts as a transcriptional activator of the PDGFRalpha gene in differentiated Tera-2 human embryonal carcinoma cells. Two mutant Pax1 proteins carrying either the undulated-mutation or the Gln --> His mutation previously identified by us in the PAX1 gene of a patient with spina bifida, were not or less effective, respectively. Surprisingly, Pax1 mutant proteins appear to have opposing transcriptional activities in undifferentiated Tera-2 cells as well as in the U-2 OS osteosarcoma cell line. In these cells, the mutant Pax1 proteins enhance PDGFRalpha-promoter activity whereas the wild-type protein does not. The apparent up-regulation of PDGFRalpha expression in these cells clearly demonstrates a gain-of-function phenomenon associated with mutations in Pax genes. The altered transcriptional activation properties correlate with altered protein-DNA interaction in band-shift assays. Our data provide additional evidence that mutations in Pax1 can act as a risk factor for NTDs and suggest that the PDGFRalpha gene is a direct target of Pax1. In addition, the results support the hypothesis that deregulated PDGFRalpha expression may be causally related to NTDs.
Subject(s)
DNA-Binding Proteins/genetics , Gene Expression Regulation , Point Mutation , Receptors, Platelet-Derived Growth Factor/genetics , Spinal Dysraphism/genetics , Transcription Factors/genetics , Transcription, Genetic , Amino Acid Substitution , Animals , Base Sequence , Carcinoma, Embryonal , DNA Primers , DNA-Binding Proteins/metabolism , Glutamine , Histidine , Humans , Mice , Mice, Mutant Strains , Molecular Sequence Data , Paired Box Transcription Factors , Promoter Regions, Genetic , Protein Biosynthesis , Receptor, Platelet-Derived Growth Factor alpha , Receptors, Platelet-Derived Growth Factor/biosynthesis , Recombinant Fusion Proteins/biosynthesis , Trans-Activators/metabolism , Transcription Factors/metabolism , Transfection , Tumor Cells, CulturedABSTRACT
It is now well recognized that periconceptional folic acid or folic acid containing multivitamin supplementation reduces the risk of neural tube defects (NTDs). Recently we were able to show that homozygosity for a thermolabile variant of the enzyme methylenetetrahydrofolate reductase is associated with an increased risk for spina bifida in patients recruited from the Dutch population. However, this genetic risk factor could not account for all folic acid preventable NTDs. In an attempt to identify additional folate related enzymes that contribute to NTD etiology we now studied the methylenetetrahydrofolate dehydrogenase gene on chromosome 14q24 which encodes a single protein with three catalytic properties important in the folate metabolism. The cDNA sequence of 38 familial and 79 sporadic patients was screened for the presence of mutations by single strand conformation polymorphism (SSCP) analysis followed by sequencing. Two amino acid substitutions were identified. The first one (R293H) was detected in a patient with familial spina bifida and not in 300 control individuals. The mutation was inherited from the unaffected maternal grandmother and was also present in two younger brothers of the index patient, one of them displaying spina bifida occulta and the other being unaffected. The second change turned out to be an amino acid polymorphism (R653Q) that was present in both patients and controls with similar frequencies. Our results so far provide no evidence for a major role of the methylenetetrahydrofolate-dehydrogenase (MTHFD) gene in NTD etiology. However, the identification of a mutation in one family suggests that this gene can act as a risk factor for human NTD.
Subject(s)
Aminohydrolases/genetics , Formate-Tetrahydrofolate Ligase/genetics , Methylenetetrahydrofolate Dehydrogenase (NADP)/genetics , Neural Tube Defects/enzymology , Neural Tube Defects/genetics , Base Sequence , DNA, Complementary , Female , Humans , Male , Methenyltetrahydrofolate Cyclohydrolase , Molecular Sequence Data , Pedigree , Polymorphism, Single-Stranded ConformationalSubject(s)
DNA-Binding Proteins/genetics , Transcription Factors , Waardenburg Syndrome/genetics , Amino Acid Sequence , Amino Acid Substitution , Base Sequence , Binding Sites , Codon, Terminator/genetics , DNA/chemistry , DNA/genetics , DNA Mutational Analysis , Family Health , Fatal Outcome , Female , Glutamine , Humans , Infant, Newborn , Methionine , Mutation , PAX3 Transcription Factor , Paired Box Transcription Factors , Point Mutation , Polymorphism, Single-Stranded Conformational , Valine , Waardenburg Syndrome/pathologyABSTRACT
Clues regarding candidate genes which influence susceptibility to spina bifida and anencephaly come from the identification of folate-associated risk factors and from studies of mouse mutants showing neural tube anomalies. On this basis we selected five candidate genes; CBS, MS, MTHFR, T (Brachyury) and BRCA1 for genetic analysis in 31 Dutch and 48 British NTD families. Ten polymorphisms, two for each gene, were used in transmission tests for disequilibrium (TDT). In six instances more than 50 transmissions from heterozygous parents could be examined. Using TDT we find evidence for an association between an allele at the T gene and liability to NTD in the embryo. Data from British and Dutch populations showed the same trend and in combination gave a chi 2TDT = 4.89, P = 0.03 (OR 2.39, CI 95% 1.02-5.61). No association, in either population group, was found for CBS, MS and MTHFR, the enzymes most directly associated with the known risk factors in folate metabolism. The possibility of complex genetic interactions was explored; the data show that a Gly919 MS variant occurs more frequently in combination with the MTHFR thermolabile variant in mothers of NTD offspring (OR 3.94, CI 95% 1.0-16.3).
Subject(s)
Fetal Proteins , Genetic Predisposition to Disease , Spinal Dysraphism/genetics , T-Box Domain Proteins , 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase/genetics , Alleles , Animals , BRCA1 Protein/genetics , Cystathionine beta-Synthase/genetics , DNA Primers , DNA-Binding Proteins/genetics , Female , Genotype , Humans , Male , Methylenetetrahydrofolate Reductase (NADPH2) , Mice , Oxidoreductases Acting on CH-NH Group Donors/genetics , Polymorphism, Genetic , Polymorphism, Single-Stranded Conformational , Sequence Analysis, DNA , Transcription Factors/geneticsABSTRACT
From studies in the mouse and from the clinical and molecular analysis of patients with type 1 Waardenburg syndrome, particular members of the PAX gene family are suspected factors in the aetiology of human neural tube defects (NTD). To investigate the role of PAX1, PAX3, PAX7, and PAX9, allelic association studies were performed in 79 sporadic and 38 familial NTD patients from the Dutch population. Sequence variation was studied by SSC analysis of the paired domain regions of the PAX1, PAX7, and PAX9 genes and of the complete PAX3 gene. In one patient with spina bifida, a mutation in the PAX1 gene was detected changing the conserved amino acid Gln to His at position 42 in the paired domain of the protein. The mutation was inherited through the maternal line from the unaffected grandmother and was not detected in 300 controls. In the PAX3 gene, variation was detected at several sites including a Thr/Lys amino acid substitution in exon 6. All alleles were present among patients and controls in about the same frequencies. However, an increased frequency of the rare allele of a silent polymorphism in exon 2 was found in NTD patients, but no significant association was observed (p = 0.06). No sequence variation was observed in the paired domain of the PAX7 and PAX9 genes. Our findings so far do not support a major role of the PAX genes examined in the aetiology of NTD. However, the detection of a mutation in PAX1 suggests that, in principle, this gene can act as a risk factor for human NTD.
Subject(s)
DNA-Binding Proteins/genetics , Genes, Homeobox/genetics , Homeodomain Proteins , Neural Tube Defects/genetics , Polymorphism, Single-Stranded Conformational , Transcription Factors/genetics , Amino Acid Sequence , DNA Mutational Analysis , Female , Glutamine/genetics , Humans , Male , Molecular Sequence Data , Muscle Proteins/genetics , Nerve Tissue Proteins/genetics , Netherlands , PAX3 Transcription Factor , PAX7 Transcription Factor , PAX9 Transcription Factor , Paired Box Transcription Factors , Pedigree , Spinal Dysraphism/geneticsABSTRACT
Alagille syndrome (AGS) or arteriohepatic dysplasia is a rare but well-defined clinical entity that is usually inherited as an autosomal dominant trait. A limited number of patients carry a deletion in chromosome 20p, with 20p11.23-p12.2 as the area of minimal overlap. Recently, a family has been identified in which a balanced translocation with a breakpoint in 20p12 co-segregates with the AGS phenotype. Here, we report a three-generation family with AGS and in which the affected members have a normal karyotype. Linkage analysis was performed with markers from the 20p candidate region. A lod score of Z = 2.96 was obtained with D20S27 at no recombination. Combining D20S27 and D20S61 to a single highly informative locus resulted in a maximum lod score of Z = +3.56 at theta = 0.0. Haplotype analysis positioned AGS between D20S59 and D20S65, markers that define an interval of about 40 cM. Allelic loss was not observed for the tested markers and no abnormalities in the PAX1 candidate gene were detected. These findings demonstrate that the locus on chromosome 20p could be responsible for AGS in cytogenetically normal patients and argues for a general role of this locus in the aetiology of AGS.
Subject(s)
Alagille Syndrome/genetics , Chromosomes, Human, Pair 20/genetics , Alagille Syndrome/epidemiology , Chromosome Mapping , Female , Humans , Indonesia/ethnology , Lod Score , Male , Netherlands/epidemiology , Pedigree , Sequence Deletion , Translocation, GeneticABSTRACT
Neural tube defects (NTD) are among the most common and disabling birth defects. The aetiology of NTD is unknown and their genetics are complex. The majority of NTD cases are sporadic, isolated, nonsyndromic, and generally considered to be multifactorial in origin. Recently, PAX3 (formerly HuP2, the human homologue of mouse Pax-3), on chromosome 2q35-37, was suggested as a candidate gene for NTD because mutations of Pax-3 cause the mouse mutant Splotch (Sp), an animal model for human NTD. Mutations in PAX3 were also identified in patients with Waardenburg syndrome type 1 (WS1). At least eight patients with both WS1 and NTD have been described suggesting pleiotropy or a contiguous gene syndrome. Seventeen US families and 14 Dutch families with more than one affected person with NTD were collected and 194 people (50 affected) from both data sets were genotyped using the PAX3 polymorphic marker. The data were analysed using affecteds only linkage analysis. The lod scores were -7.30 (US), -3.74 (Dutch), and -11.04 (combined) at theta = 0.0, under the assumption of the autosomal dominant model. For the recessive model, the lod scores were -3.30 (US), -1.46 (Dutch), and -4.76 (combined) at theta = 0.0. Linkage between PAX3 and familial NTD was excluded to 9.9 cM on either side of the gene for the dominant model and to 3.63 cM on either side of the gene for the recessive model in the families studied. No evidence of heterogeneity was detected using the HOMOG program. Our data indicate that PAX3 is not a major gene for NTD.
Subject(s)
DNA-Binding Proteins/genetics , Genetic Linkage , Neural Tube Defects/genetics , Transcription Factors , Base Sequence , Family Health , Female , Genetic Markers , Humans , Male , Molecular Sequence Data , PAX3 Transcription Factor , Paired Box Transcription Factors , Pedigree , Polymorphism, GeneticABSTRACT
Neural tube defects (NTD) are among the most prevalent congenital malformations in man. Based on the molecular defect of Splotch, an established mouse model for NTD, and on the clinical association between NTD and Waardenburg syndrome (WS), mutations in the PAX3 gene can be expected to act as factors predisposing to human NTD. To test this hypothesis, 39 patients with familial NTD were screened by SSC analysis for mutations in exons 2 to 6 of the human PAX3 gene. One patient with lumbosacral meningomyelocele was identified with a 5 bp deletion in exon 5 approximately 55 bp upstream of the conserved homeodomain. The deletion causes a frameshift with a stop codon almost immediately after the mutated site. Clinical investigation of the index patient indicated mild signs of WS type I. Varying signs of this syndrome were found to cosegregate with the mutation in the family. Our results support the hypothesis that mutations in the gene for PAX3 can predispose to NTD, but also show that, in general, mutations within or near the conserved domains of the PAX3 protein are only very infrequently involved in familial NTD.